FDA approves new kind of cholesterol pill
LipfendraPCSK9 inhibitorFDA approvalLDL cholesterolcholesterol reductionhypercholesterolemia.
Author: mgh2
Date: 7/19/2026
Article Summary:
The FDA approves Lipfendra, the first oral PCSK9 inhibitor, to reduce LDL cholesterol in adults with high cholesterol.